These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

31 related articles for article (PubMed ID: 668780)

  • 1. Comparative study of the haemodynamic effects of oral molsidomine and isosorbide dinitrate in man.
    Vogt A; Kreuzer H
    Eur J Clin Pharmacol; 1982; 23(1):11-4. PubMed ID: 6897039
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Effects of molsidomine on the coronary circulation in anesthetized dogs.
    Fiedler VB; Nitz RE
    Basic Res Cardiol; 1982; 77(3):270-7. PubMed ID: 6896818
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Effect of molsidomine on hemodynamics and myocardial ischemia in patients with acute myocardial infarction (author's transl)].
    Bussmann WD; Neidl K; Kaltenbach M
    Klin Wochenschr; 1982 Jan; 60(2):77-85. PubMed ID: 6896077
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Increased effective vascular compliance and venous pooling of intravascular volume during sustained venodilation in conscious dogs.
    Holtz J; Bassenge E; Kinadeter H; Kolin A
    Basic Res Cardiol; 1981; 76(6):657-69. PubMed ID: 6895845
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effects of molsidomine, nitroglycerin, and isosorbide dinitrate on the coronary circulation, myocardial oxygen consumption, and haemodynamics in anaesthetized dogs.
    Fiedler VB; Nitz RE
    Naunyn Schmiedebergs Arch Pharmacol; 1981 Aug; 317(1):71-7. PubMed ID: 6792547
    [No Abstract]   [Full Text] [Related]  

  • 6. Haemodynamic effects of oral molsidomine in pump failure complicating myocardial infarction.
    Drajer S; Cercós H; Torres H; Vazquez A; Cohn JL; Romero N; Faerman G; Soifer S; Nijensohn CM
    Eur J Clin Pharmacol; 1984; 27(4):419-22. PubMed ID: 6549166
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Intravenous and oral administration of molsidomine, a pharmacodynamic and pharmacokinetic study.
    Bergstrand R; Vedin A; Wilhelmsson C; Peterson LE; Chamberlain J; Dell D; Stevens LA; Ostrowski J
    Eur J Clin Pharmacol; 1984; 27(2):203-8. PubMed ID: 6548711
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Pharmacokinetics of molsidomine and its active metabolite, linsidomine, in patients with liver cirrhosis.
    Spreux-Varoquaux O; Doll J; Dutot C; Grandjean N; Cordonnier P; Pays M; Andrieu J; Advenier C
    Br J Clin Pharmacol; 1991 Sep; 32(3):399-401. PubMed ID: 1777378
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Haemodynamic effects of molsidomine in patients with severe chronic coronary disease.
    Crexells C; Lidón RM; Augé JM; Bosch X; Pina C; Garcia J; Oriol A
    Eur Heart J; 1985 Dec; 6(12):1032-9. PubMed ID: 3841658
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Haemodynamic effects of molsidomin.
    Karsch KR; Rentrop KP; Blanke H; Kreuzer H
    Eur J Clin Pharmacol; 1978 Jun; 13(4):241-5. PubMed ID: 668780
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Hemodynamic actions of molsidomin in coronary artery disease. Effects on regional myocardial blood flow, segmental ventricular wall motion, ejection phase parameters, ventricular volumes, systemic and pulmonary artery pressures and cardiac output (author's transl)].
    Fleck E; Dirschinger J; Rudolph W
    Herz; 1979 Jun; 4(3):285-92. PubMed ID: 457027
    [No Abstract]   [Full Text] [Related]  

  • 12. [Effects of molsidomin on left ventricular function and volume in patients with coronary heart disease (author's transl)].
    Karsch KR; Blanke H; Kreuzer H; Rentrop KP
    Z Kardiol; 1979 Feb; 68(2):71-6. PubMed ID: 425616
    [No Abstract]   [Full Text] [Related]  

  • 13. [The effect of molsidomin on the arterial windkessel (author's transl)].
    Sauer G; Tebbe U; Krause H; Kreuzer H; Neuhaus KL
    Z Kardiol; 1981 Sep; 70(9):713-8. PubMed ID: 6895435
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [An improved exercise test in coronary-heart disease: effect of molsidomin on erogometrically controlled exercise (author's transl)].
    Blazek G; Heeger H; Kubicek F
    Dtsch Med Wochenschr; 1977 Jan; 102(3):81-4. PubMed ID: 832584
    [TBL] [Abstract][Full Text] [Related]  

  • 15.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 16.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 17.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 18.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 19.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 20.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 2.